Literature DB >> 25301277

Role of adenosine receptor subtypes in methamphetamine reward and reinforcement.

Kevin A Kavanagh1, Drew C Schreiner1, Sophia C Levis1, Casey E O'Neill1, Ryan K Bachtell2.   

Abstract

The neurobiology of methamphetamine (MA) remains largely unknown despite its high abuse liability. The present series of studies explored the role of adenosine receptors on MA reward and reinforcement and identified alterations in the expression of adenosine receptors in dopamine terminal areas following MA administration in rats. We tested whether stimulating adenosine A1 or A2A receptor subtypes would influence MA-induced place preference or MA self-administration on fixed and progressive ratio schedules in male Sprague-Dawley rats. Stimulation of either adenosine A1 or A2A receptors significantly reduced the development of MA-induced place preference. Stimulating adenosine A1, but not A2A, receptors reduced MA self-administration responding. We next tested whether repeated experimenter-delivered MA administration would alter the expression of adenosine receptors in the striatal areas using immunoblotting. We observed no change in the expression of adenosine receptors. Lastly, rats were trained to self-administer MA or saline for 14 days and we detected changes in adenosine A1 and A2A receptor expression using immunoblotting. MA self-administration significantly increased adenosine A1 in the nucleus accumbens shell, caudate-putamen and prefrontal cortex. MA self-administration significantly decreased adenosine A2A receptor expression in the nucleus accumbens shell, but increased A2A receptor expression in the amygdala. These findings demonstrate that MA self-administration produces selective alterations in adenosine receptor expression in the nucleus accumbens shell and that stimulation of adenosine receptors reduces several behavioral indices of MA addiction. Together, these studies shed light onto the neurobiological alterations incurred through chronic MA use that may aid in the development of treatments for MA addiction.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Place conditioning; Psychostimulant; Purine; Self-administration

Mesh:

Substances:

Year:  2014        PMID: 25301277      PMCID: PMC4250385          DOI: 10.1016/j.neuropharm.2014.09.030

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  63 in total

1.  Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M Sedler; S J Gatley; E Miller; R Hitzemann; Y S Ding; J Logan
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

2.  Agonists of A1 and A2A adenosine receptors attenuate methamphetamine-induced overflow of dopamine in rat striatum.

Authors:  K Golembiowska; A Zylewska
Journal:  Brain Res       Date:  1998-09-28       Impact factor: 3.252

3.  Effects of adenosine A1- and A2A-receptor agonists on enhancement of dopamine release from the striatum in methamphetamine-sensitized rats.

Authors:  A Yoshimatsu; T Shimazoe; A Kawashimo; T Shuto; Y Doi; T Fukumoto; S Watanabe
Journal:  Jpn J Pharmacol       Date:  2001-06

4.  Role of dopamine D1- and D2-like receptor mechanisms in drug-seeking following methamphetamine self-administration in rats.

Authors:  Caleb Carati; Susan Schenk
Journal:  Pharmacol Biochem Behav       Date:  2011-02-17       Impact factor: 3.533

5.  Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus.

Authors:  T V Dunwiddie; B B Fredholm
Journal:  J Pharmacol Exp Ther       Date:  1989-04       Impact factor: 4.030

Review 6.  The role and regulation of adenosine in the central nervous system.

Authors:  T V Dunwiddie; S A Masino
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

7.  Adenosine receptor-mediated modulation of acetylcholine release from rat striatal synaptosomes.

Authors:  K A Kirkpatrick; P J Richardson
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

8.  SCH 23390 equivalently, but YM-09151-2 differentially reduces the stimulant effects of methamphetamine, MK-801 and ketamine: assessment by discrete shuttle avoidance in mice.

Authors:  H Kuribara; Y Uchihashi
Journal:  Jpn J Pharmacol       Date:  1993-05

9.  Effects of adenosine A2A receptor stimulation on cocaine-seeking behavior in rats.

Authors:  Ryan K Bachtell; David W Self
Journal:  Psychopharmacology (Berl)       Date:  2009-07-30       Impact factor: 4.530

10.  Adenosine receptors and behavioral actions of methylxanthines.

Authors:  S H Snyder; J J Katims; Z Annau; R F Bruns; J W Daly
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

View more
  10 in total

1.  HIV-1 TAT protein enhances sensitization to methamphetamine by affecting dopaminergic function.

Authors:  James P Kesby; Julia A Najera; Benedetto Romoli; Yiding Fang; Liana Basova; Amanda Birmingham; Maria Cecilia G Marcondes; Davide Dulcis; Svetlana Semenova
Journal:  Brain Behav Immun       Date:  2017-05-08       Impact factor: 7.217

Review 2.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

3.  Role of dopamine D2-like receptors and their modulation by adenosine receptor stimulation in the reinstatement of methamphetamine seeking.

Authors:  Tracey A Larson; Madeline C Winkler; Jacob Stafford; Sophia C Levis; Casey E O'Neill; Ryan K Bachtell
Journal:  Psychopharmacology (Berl)       Date:  2018-11-23       Impact factor: 4.530

Review 4.  Quantity versus quality: Convergent findings in effort-based choice tasks.

Authors:  Evan E Hart; Alicia Izquierdo
Journal:  Behav Processes       Date:  2019-05-11       Impact factor: 1.777

5.  Brain Reward Function after Chronic and Binge Methamphetamine Regimens in Mice Expressing the HIV-1 TAT Protein.

Authors:  James P Kesby; Ariel Chang; Julia A Najera; Maria Cecilia G Marcondes; Svetlana Semenova
Journal:  Curr HIV Res       Date:  2019       Impact factor: 1.581

Review 6.  Sleep and alertness disturbance and substance use disorders: A bi-directional relation.

Authors:  Timothy Roehrs; Mohammad Sibai; Thomas Roth
Journal:  Pharmacol Biochem Behav       Date:  2021-02-12       Impact factor: 3.533

7.  Effects of an adenosine A2A agonist on the rewarding associative properties of nicotine and neural plasticity in a rodent model of schizophrenia.

Authors:  Wesley Drew Gill; Heath W Shelton; Katherine C Burgess; Russell W Brown
Journal:  J Psychopharmacol       Date:  2019-11-07       Impact factor: 4.562

8.  Methamphetamine self-administration reduces alcohol consumption and preference in alcohol-preferring P rats.

Authors:  Madeline C Winkler; Emilee M Greager; Jacob Stafford; Ryan K Bachtell
Journal:  Addict Biol       Date:  2016-11-16       Impact factor: 4.280

Review 9.  Adenosine A2AReceptors in Substance Use Disorders: A Focus on Cocaine.

Authors:  Karolina Wydra; Dawid Gawliński; Kinga Gawlińska; Małgorzata Frankowska; Dasiel O Borroto-Escuela; Kjell Fuxe; Małgorzata Filip
Journal:  Cells       Date:  2020-06-01       Impact factor: 6.600

Review 10.  The Role of Adenosine Receptors in Psychostimulant Addiction.

Authors:  Inmaculada Ballesteros-Yáñez; Carlos A Castillo; Stefania Merighi; Stefania Gessi
Journal:  Front Pharmacol       Date:  2018-01-10       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.